Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Recommendation of “Hold” by Brokerages
Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have received a consensus rating of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the […]
Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have received a consensus rating of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the […]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
